Search
Stevanato Group SpA
STVNAdd to Watchlist
19.010USD
+0.670+3.65%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.75BMarket Cap
42.41P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Stevanato Group SpA is 8.33, ranking 51 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 28.00, with a high of 37.00 and a low of 23.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
25.175
Target Price
+45.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Stevanato Group SpA
STVN
12
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Abbott Laboratories
ABT
31
Stryker Corp
SYK
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Stevanato Group SpA's expected revenue for the next quarter?
Stevanato Group SpA's expected revenue is 341.84M.
What is Stevanato Group SpA's price target?
Analysts forecast that Stevanato Group SpA's price target is USD 28.00, with the highest forecast at USD 37.00 and the lowest forecast at USD 23.00.
How have Stevanato Group SpASTVN's recent earnings per share performed?
The market expectation was USD 0.12, while Stevanato Group SpASTVN's earnings per share (EPS) for the previous quarter was USD 0.20. EPS for the next quarter is expected at USD 0.15.
What is the analyst rating for Stevanato Group SpA?
Based on the ratings of Stevanato Group SpA's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.